Phase 2 Readout~quarter

Phase 2 Readout: namodenoson

Indication
pancreatic cancer

Other upcoming events for CANF

Phase 2 ReadoutPhase 2 Readout: piclidenoson
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Daily Pi

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: namodenoson — CANF Phase 2 Readout | BioSniper